DEA Considers Reclassifying Cannabis as Medicine: What It Means for Patients and Research0
- MEDICAL MARIJUANA
- July 3, 2024
In a groundbreaking move, the Drug Enforcement Administration (DEA) is proposing regulations that would reclassify cannabis as medicine rather than an illicit drug. This potential shift to Schedule III classification could have far-reaching implications for both patients and researchers. While cannabis would still be available at state-authorized dispensaries, the reclassification could pave the way for
READ MORE












